ライフサイエンスコーパス: bone graft

1 s the percentage mineralization of the final bone graft.

2 implant placed by this technique without any bone graft.

3 ion of enamel matrix proteins and autogenous bone graft.

4 imally invasive surgical approach to place a bone graft.

5 delivered in a collagen sponge, as in InFUSE Bone Graft.

6 ne than when they were mixed with the bovine bone graft.

7 th preoperative DA only in the group without bone graft.

8 d in combination with autologous iliac crest bone graft.

9 ion following minor surgery with ;low-volume bone graft.

10 orthopedic surgery requiring a small-volume bone graft.

11 revious cases of allosensitization following bone graft.

12 is essential for optimal functioning of the bone graft.

13 th a titanium-mesh technique and particulate bone graft.

14 nd tetracycline (TCN) on the repair of onlay bone grafts.

15 stem to the extent requiring implantation of bone grafts.

16 s like compressive strength for load-bearing bone grafts.

17 microvascular networks for tissue engineered bone grafts.

18 demand for functional implants, particularly bone grafts.

19 erived from black liquor was used to develop bone grafts.

20 neration and enhance the healing efficacy of bone grafts.

21 ficantly between the groups with and without bone grafts.

22 tes as an alternative method to conventional bone grafts.

23 dure has never been evaluated in particulate bone grafts.

24 wever, there is little information regarding bone grafts.

25 limited the clinical use of ionic silver for bone grafts.

26 emineralization can improve consolidation in bone grafts.

27 nstructed with Le Fort I osteotomy and iliac bone grafting.

28 Case 1 did not need additional bone grafting.

29 efects contain skeletal components requiring bone grafting.

30 our quest to find new techniques to enhance bone grafting.

31 engineering is an exciting new technique in bone grafting.

32 18 and followed up more than 24 months after bone grafting.

33 rapy with enamel matrix derivative (EMD) and bone grafting.

34 of infection at a mean of 18.5 months after bone grafting.

35 T) with and without alveolar corticotomy and bone grafting.

36 therapy using EMD with or without autologous bone grafting, 282 intrabony defects of 177 participants

37 ups: (1) unrepaired controls, (2) autologous bone grafts, (3) unseeded Caprotite (a polymer-ceramic c

38 ve control); 2) defects treated with nano-HA bone graft; 3) defects treated with micro-HA bone graft;

39 centrated growth factor (CGF) and autogenous bone graft (ABG) in the treatment of intrabony pockets a

40 nd platelet-rich fibrin (L-PRF) + autogenous bone graft (ABG) may be a clinically "non-inferior" trea

41 d platelet-rich fibrin (L-PRF) to autogenous bone grafts (ABGs) in the treatment of mandibular molar

42 tion properties of enamel matrix proteins to bone grafts after surface coating with either EMD (as a

43 d better results when compared with IIP with bone graft alone [CBL changes of 0.532 +/- 0.572 mm].

44 d better results when compared with IIP with bone graft alone [CBL changes of 0.532 0.572 mm].

45 sing GBR versus IIP without GBR", "IIP using bone graft alone versus IIP using bone graft with membra

46 The collagenated bone graft alone yielded comparable outcomes to its comb

47 nd treated with SA-PAE/bone graft mixture or bone graft alone.

48 tic rats compared to diabetic rats receiving bone graft alone.

49 ared to the non-antibiotic-loaded barrier or bone graft alone.

50 mal matrix, and nine sites were treated with bone graft alone.

51 tter CBL preservation compared with IIP with bone graft alone.

52 d in 3D printable bio-ink to generate viable bone graft alternatives for cranial reconstruction.

53 History of bone grafting alters the clinical, physiological, and mo

54 ntities normally associated with periodontal bone grafting, although they do support the use of this

55 ay enhance the physical connection between a bone graft and a recipient site.

56 ata suggests GTR using allogeneic cancellous bone graft and absorbable collagen membrane to be a viab

57 f the contacting surfaces between autologous bone graft and bone bed improved new bone formation and

58 e model to investigate the effect of various bone graft and bone replacement materials on extraction

59 ated with GTR using an allogeneic cancellous bone graft and covered by an absorbable membrane with at

60 al thoracic or lumbar fusion with autologous bone graft and instrumentation more than 9 months previo

61 hBMP-2 has no proven clinical advantage over bone graft and may be associated with important harms, m

62 However, IIP with bone graft and membrane reported better CBL preservation

63 However, IIP with bone graft and membrane showed better results when compa

64 However, IIP with bone graft and membrane showed better results when compa

65 The contacting surfaces between bone graft and receptor bone bed were demineralized for

66 oval of the tooth and restoring the gap with bone graft and sealing the socket with mucosagraft from

67 ct management (detoxification and mixture of bone graft and tetracycline).

68 BL around IIP with bone graft versus without bone graft and with IIP with GBR compared with conventio

69 These procedures typically include a bone graft and/or membrane therapy.

70 d for periodontal surgeries with and without bone grafting and acceptability of guidelines.

71 Advances concerning bone grafting and arthroplasty procedures have resulted

72 re more likely to prescribe antibiotics with bone grafting and as complexity of the bone grafting pro

73 and CBVT images were taken prior to initial bone grafting and at the 6-month reentry surgery for 35

74 th a second graft site needed for autologous bone grafting and facilitate the surgical procedure.

75 implants using a surgical guide, performing bone grafting and soft tissue grafting at the time of im

76 urally throughout life); one was filled with bone grafts and barrier membranes, while the other was l

77 in this paper include the use of particulate bone grafts and bone graft substitutes, barrier membrane

78 rix material as an alternative to autogenous bone grafts and demineralized cadaver bone to support th

79 Collectively, studies support the use of bone grafts and guided tissue regeneration (GTR) for the

80 shown to be advantageous in autogenous onlay bone grafts and in pre-osteoblasts cultures, but such pr

81 defects by guided tissue regeneration using bone grafts and membranes have not always yielded predic

82 generation success may be limited by placing bone grafts and membranes in infected sites.

83 rating osteogenesis at the interface between bone grafts and receptor bone beds, especially when appl

84 bone graft; 3) defects treated with micro-HA bone graft; and 4) defects treated with a mixed composit

85 Autologous bone grafts are considered the gold standard grafting ma

86 aware of the risk of allosensitization where bone grafts are used.

87 Autologous bone grafts are usually well consolidated after 4 to 5 m

88 onv) alveolar decortication and augmentation bone grafting, are matched in this case-control study fo

89 Bone grafting as a gold standard of bone repairing is li

90 be utilized as an advantageous interface for bone grafts as they can promote angiogenesis, which impr

91 d into test and control groups: Test: bovine bone graft associated with porcine collagen and collagen

92 collagen membrane was used; control: bovine bone graft associated with porcine collagen was used wit

93 Guided implant surgery, bone grafting at implant placement, soft tissue augmenta

94 Bone grafting at time of placement was required in 25% o

95 conventional arterial flap (cAF, n = 6) and bone graft (BG, n = 6).

96 e groups: open flap debridement [OFD] alone, bone graft [BG], and bone graft plus a bioabsorbable col

97 n debridement with a bioabsorbable synthetic bone graft, bioabsorbable membrane, and minocycline root

98 lly sized, anatomically shaped, viable human bone grafts can be engineered by using human mesenchymal

99 after the removal of an LPC, GTR, along with bone grafting, can be a very useful tool for its treatme

100 or traditional periodontal surgeries without bone grafting compared with socket preservation, guided

101 ggest that bone demineralization may promote bone graft consolidation as well as proliferation and di

102 However, data on the vertical course of bone graft consolidation within the maxillary sinus are

103 and to characterize the vertical gradient of bone graft consolidation.

104 e Fort I osteotomy and interpositional iliac bone grafting could be considered a viable protocol to r

105 lack of guidelines for procedures involving bone grafts creates additional difficulty in decision ma

106 found that the addition of PRP to xenogenic bone grafts demonstrated a low regenerative potential in

107 o reduce soft tissue exposure and to improve bone graft density and volume after augmentation.

108 T cells that underwent negative selection on bone graft derived I-E+ cells within the thymus.

109 action sockets or combined with freeze-dried bone graft (FDBG) to fill rat calvarial osseous defects.

110 plications, including drug-delivery systems, bone-graft fillers and medical devices.

111 onsistently and successfully expanded before bone graft for ridge augmentation even at sites with a h

112 mplex geometries-to provide patient-specific bone grafts for craniofacial and orthopedic reconstructi

113 seed synthetic and decellularized allogeneic bone grafts for enhancement of scaffold remodeling and f

114 t approval of NMF such as GEM 21S and INFUSE bone grafts for periodontal and oral regenerative therap

115 scaffolds to be used in place of autologous bone grafts for the treatment of critical size defects,

116 essfully applied to hESC progenitors to grow bone grafts for use in basic and translational studies.

117 portive peri-implant maintenance, and use of bone graft) for peri-implant mucositis and three predict

118 s were performed on unoperated limbs, and in bone grafts from two pigs that had autograft procedures

119 lagen-based resorbable membrane and a bovine bone graft (GM defect), the left side remained empty (em

120 t differences between DBBM-C and control (no bone graft) groups.

121 In the larger lesions, EMD plus autogenous bone graft had 3.24 mm new bone height compared to 2.71

122 th other materials without the necessity for bone-graft harvesting or a second procedure to remove th

123 Traditionally, bone grafts have been used to restore damaged bone.

124 igates the effect of PTH(1-34) on autogenous bone graft healing.

125 ial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allogr

126 imed to demonstrate that an inorganic bovine bone graft (IBB) in combination with a leukocyte and pla

127 in-NGFR+ cells were used to repopulate human bone grafts implanted in severe combined immunodeficient

128 combined therapy has been proposed, using a bone graft in combination with EMD to avoid collapse of

129 e graft was better than micro-HA or mixed-HA bone graft in new bone formation in standardized surgica

130 The addition of bone graft in small-to-medium size lesions did not affec

131 with a 1:1 mixture of autologous PRF and HA bone graft in the surgical treatment of mandibular Class

132 wall, for yielding the additional benefit of bone grafting in combination with periodontal regenerati

133 Adults scheduled to receive bone grafting in maxillary, non-molar, single-tooth extr

134 n DA at baseline >=40 degrees and adjunctive bone grafting in the reduction of RBD, regardless of the

135 The human bone grafts in either fiber or particle form used alone

136 PVR is potentially a reliable indicator of bone graft incorporation and can aid in clinical decisio

137 One of the major challenges in bone grafting is the lack of sufficient bone vasculariza

138 and rehabilitation of atrophic maxillae with bone grafts is a lengthy and demanding procedure.

139 or the treatment of an infrabony defect (the bone graft material [BG], the biologic agent, the applic

140 us bone graft, which were simulated by using bone graft material from syngeneic ACTB-eGFP-expressing

141 hPDGF-BB, and rhBMP-2) in combination with a bone graft material generally results into superior hist

142 sults demonstrate that this anorganic bovine bone graft material is able to support the attachment an

143 The fiber bone graft material resorbed more rapidly relative to th

144 tudies to 1) examine the interaction of this bone graft material with PDGF-BB and IGF-I and 2) determ

145 n these studies the cells were seeded on the bone graft material, then the material was removed and p

146 decreasing the DBM content per volume of the bone graft material.

147 y enhances the osteogenic properties of this bone graft material.

148 to the presence or absence of the composite bone graft material.

149 d in combination with a cow-derived (bovine) bone graft material.

150 were observed regarding percent of remaining bone grafting material and non-mineralized tissue.

151 Porous hydroxyapatite (HA) bone grafting material has a clinically satisfactory res

152 Porous hydroxyapatite (HA) bone grafting material has been used to fill periodontal

153 ermine the effect that socket filling with a bone grafting material has on the prevention of postextr

154 However, a specific bone grafting material that is patently superior has not

155 Total protein adsorption to bone grafting material was quantified using an enzyme-li

156 Autologous bone is the most successful bone-grafting material; however, limited supply and dono

157 ne the time taken for complete resorption of bone graft materials and their replacement with new bone

158 Bone graft materials are needed in periodontics that are

159 ected histologic wound healing data on human bone graft materials in a fiber and particle form alone

160 d enrolled in the study, and one of the four bone graft materials was placed in the site.

161 ta-TCP or CaSO(4) to serve as more effective bone graft materials with enhanced osteogenic properties

162 valuate and compare the healing of different bone grafting materials adjacent to titanium plasma-spra

163 tion of exogenous proteins to the surface of bone grafting materials and the subsequent cellular beha

164 General trends in synthetic bone grafting materials are shifting towards approaches

165 tion of EMD combined with different types of bone grafting materials in periodontal regenerative proc

166 linical esthetic outcome, when two different bone grafting materials were used.

167 ity of adsorbed amelogenin to the surface of bone grafting materials when enamel matrix proteins were

168 y defects using native collagen membrane and bone grafting materials.

169 nt; 2) surgical resection; 3) application of bone grafting materials; and 4) guided bone regeneration

170 Additional treatment such as a bone graft may be considered especially in large cysts.

171 nsplantation of bone marrow in the form of a bone graft may facilitate the production of hematopoieti

172 safe prophylactic antimicrobial protocol in bone grafting may enhance osseous volume outcomes.

173 al methods of procuring mandibular symphysis bone grafts may leave soft tissue scarring, and cause pa

174 es to be widely used, for example, in InFUSE Bone Graft (Medtronic).

175 The most effective option included bone grafts, membranes, and laser treatment (56 euros pe

176 variables was examined including the use of bone grafts, membranes, soft tissue grafts, post-surgica

177 rat mandibular angle and treated with SA-PAE/bone graft mixture or bone graft alone.

178 used in conjunction with pliable atraumatic bone grafting mixture and hydraulic pressure from a surg

179 28) in which there are Sub-group A: without bone graft (n = 14) and Sub-group B: with composite bone

180 28) in which there are Sub-group A: without bone graft (n = 14) and Sub-group B: with composite bone

181 aft (n = 14) and Sub-group B: with composite bone graft (n = 14).

182 aft (n = 14) and Sub-group B: with composite bone graft (n = 14).

183 is to retrospectively evaluate the effect of bone grafting of the defect between the bone crest and t

184 itical hurdle-in vitro cultivation of viable bone grafts of complex geometries-to provide patient-spe

185 Within bone grafts of this size and complexity cells were fully

186 ncrease after decortication and augmentation bone grafting offsets the concerns of orthodontic procli

187 latelet-rich plasma (PRP) added to xenogenic bone grafts on bone histomorphometric parameters in a do

188 cally correct regenerate that is better than bone grafting or revascularised free-tissue transfer.

189 vorably with the treatment results utilizing bone grafts or membrane barriers, according to published

190 repair response of bioactive glass synthetic bone graft particles and open debridement in the treatme

191 NBM and DFDBA and adsorb to the interior of bone grafting particles.

192 defects compared with autologous PRF and HA bone graft placed after open-flap debridement (OFD).

193 1.5 mm in Case 2, which required particulate bone graft placement.

194 servation after tooth extraction: one with a bone graft plug alone, and the other with the bone graft

195 one graft plug alone, and the other with the bone graft plug plus a collagen membrane.

196 FDBA and DFDBA had more total bone (grafted plus new) present than E at all time perio

197 ebridement [OFD] alone, bone graft [BG], and bone graft plus a bioabsorbable collagen membrane [BG +

198 l therapeutic modalities, such as autologous bone grafting, present myriad limitations and carry with

199 one defect, alveolar ridge preservation with bone grafts prior to implant placement is often needed.

200 ical protocol, and elevated ESR before final bone graft procedure.

201 with bone grafting and as complexity of the bone grafting procedure increases.

202 This has the potential to revolutionise bone graft procedures by creating cellular graft materia

203 quelae related to implant placement/advanced bone grafting procedures are a result of injury to surro

204 Bone grafting procedures have become increasingly common

205 Bone grafting procedures were performed at 194 sites in

206 However, millions of oral and non-oral bone-grafting procedures are performed annually, and onl

207 able role in the detection of posterolateral bone graft pseudarthrosis, especially when hardware is p

208 Bone grafting remains the standard treatment for bone de

209 lls has been recognized, vascularizing large bone grafts remains a challenge and has apprehended the

210 ucidated important aspects of the biology of bone graft remodeling and osteoprogenitor cell different

211 mplant dimensions, history of periodontitis, bone graft, restoration angle, emergence, smoking, and d

212 with alveolar decortication and augmentation bone grafting resulted in a significant increase in KT h

213 l combined with autologous PRF and porous HA bone graft results in significant improvements of clinic

214 a (RR 1.1 [1.0-1.2]), requirement for tibial bone graft (RR 2.0 [1.3-2.7]), use of posterior stabilis

215 ID mice implanted with bilateral human fetal bone grafts (SCID-hu mice).

216 owed that the addition of biologic agents to bone graft significantly improves the clinical and radio

217 f midline were evaluated for the presence of bone graft, solid fusion, clefts, fluid collections, and

218 of enamel matrix derivative plus autogenous bone graft stimulated statistically significant periodon

219 e transmission from a commercially available bone graft substitute (BGS) that is popularly used in cl

220 calcium phosphate/calcium sulfate (B-TCP/CS) bone graft substitute for compatibility with vancomycin

221 rphogenetic protein-2 (rhBMP-2) is used as a bone graft substitute in spinal fusion, which unites (fu

222 Assessment of bone graft substitute incorporation is critical in the c

223 Surgical intervention with PTG used as a bone graft substitute was performed in 10 patients with

224 ith GTR using a bioabsorbable membrane and a bone graft substitute with at least 1-year follow-up wer

225 point for further discoveries of therapeutic bone-graft substitute materials.

226 The review includes an overview of bone graft substitutes and biological adjuncts to bone-r

227 otential to be used in novel, cost-effective bone graft substitutes for either achieving spinal fusio

228 clude the use of particulate bone grafts and bone graft substitutes, barrier membranes for guided bon

229 Synthetic biomaterials are now being used as bone graft substitutes.

230 rently available for clinical application as bone graft substitutes.

231 ring and 3D bioprinting to engineer superior bone graft substitutes.

232 y to prescribe antibiotics with more complex bone grafting such as guided bone regeneration and sinus

233 Conventional bone grafts such as xenografts, allografts, and syntheti

234 nancies, and other diseases is treated using bone-grafting techniques that suffer from numerous short

235 of this construct was compared to autologous bone graft, the clinical standard of care in pediatric c

236 NLR) were calculated in each patient for the bone graft, the contralateral normal side, and the spine

237 ll remains the undisputed "gold standard" in bone grafting, the realization that bone requirement in

238 with the exception of defect fill following bone grafting, the reduction in variability in clinical

239 e treated with Le Fort I osteotomy and iliac bone grafting to allow for implant-borne prosthetic reha

240 switched abutments; 3) flapless approach; 4) bone grafts to fill the gap between buccal plate and fix

241 is systematic review, PhMT-b via particulate bone grafting together with CAOT may provide clinical be

242 Nude bone graft transplantation into SCID recipients resulted

243 Using a murine segmental bone graft transplantation model, we isolated a populati

244 At defined time points after bone graft transplantation recipients were assayed for c

245 bined blockade of the CD40 and CD28 pathways bone graft transplantation resulted in long-term donor-s

246 In the absence of an immunological barrier, bone graft transplantation resulted in long-term multi-l

247 d with T cells at a physiologic rate by nude bone graft transplantation.

248 sed significantly at 4 and 12weeks in SA-PAE/bone graft-treated diabetic rats compared to diabetic ra

249 ation in normoglycemic rats caused by SA-PAE/bone graft treatment was observed at 4weeks but not at 1

250 Large bone grafts used for ridge reconstruction purposes might

251 of the detached cementum in combination with bone grafting using a minimally invasive surgical approa

252 al debridement, supracrestal implantoplasty, bone grafting using a mixture of human allograft with de

253 o-stage protocol for generating vascularized bone grafts using mesenchymal stem cells (hMSCs) from hu

254 ed minimal difference in CBL around IIP with bone graft versus without bone graft and with IIP with G

255 parison of computed tomographic scans before bone grafting versus 4 to 6 months after bone grafting w

256 ation recipients were assayed for chimerism, bone graft viability, and responses to donor and third p

257 study demonstrated that nano-hydroxyapatite bone graft was better than micro-HA or mixed-HA bone gra

258 ibodies following orthopedic surgery where a bone graft was deployed intraoperatively.

259 The amount of new bone formed with nano-HA bone graft was highly more significant than that obtaine

260 ter ideal osteotomy preparation, particulate bone graft was placed in the osteotomy and appropriately

261 e cyst's removal, a decalcified freeze-dried bone graft was placed to close the defect.

262 ore bone grafting versus 4 to 6 months after bone grafting was performed.

263 n rationale for prescribing antibiotics with bone grafting was to decrease the chances of developing

264 lumbar spine fusion, rhBMP-2 and iliac crest bone graft were similar in overall success, fusion, and

265 Bone grafts were harvested from the calvarium of rats wi

266 The bone grafts were immobilized by a resorbable membrane gl

267 Onlay bone grafts were performed on the calvaria of 126 Wistar

268 Onlay bone grafts were performed on the calvaria of 36 guinea

269 use they reduce the inevitable resorption of bone grafts when used alone.

270 ecrotic defects were treated with autologous bone graft, which were simulated by using bone graft mat

271 esents a promising alternative to autologous bone grafting, which is considered the current gold stan

272 ion, short-term stabilization, and long-term bone grafting, which may include problematic allografts

273 nd alveolar defects comparable to autogenous bone graft with favorable biodegradation of the bioactiv

274 "IIP using bone graft alone versus IIP using bone graft with membrane" and "IIP using GBR versus conv

275 Adjunctive autologous bone grafting with enamel matrix derivative might be sig

276 rnover and inflammation after extraction and bone grafting with or without local simvastatin (SIM).

277 in cAF and AVF was significantly superior to bone grafts with a higher bone volume in AVFs (p = 0.01)

278 Functionalization of conventional bone grafts with a tailored peptide amphiphile nanofiber

279 Demineralization of particulate bone grafts with CA during 15s enhanced the regeneration

280 econstructive therapy can include the use of bone grafts with limited predictability and efficacy.

281 newly developed calcium metaphosphate (CMP) bone graft, with and without bone-stimulating growth fac

282 one marrow microenvironment in the form of a bone graft would permit stable hematopoietic stem cell e

283 ve root-end filling materials with composite bone graft (xenogeneic mixed with autogenous bone fragme

284 ded that the minimally invasive approach for bone grafting yielded results that were equivalent to mo